Skip to main content

Posters

Recent Posters

Posters  —  5 February Feb 2025

A robust adoptive cell therapy phenotyping panel for assessing cerebrospinal fluid during and after neurotoxicity by flow cytometry

Read More about A robust adoptive cell therapy phenotyping panel for assessing cerebrospinal fluid during and after neurotoxicity by flow cytometry
Posters  —  5 February Feb 2025

Validation of a flow cytometry-based basophil degranulation assay for use in multi-centric clinical trials

Read More about Validation of a flow cytometry-based basophil degranulation assay for use in multi-centric clinical trials
Posters  —  27 November Nov 2024

Unmasking Crohn’s Disease: Anti-glycan antibodies (ACCA, ALCA, AMCA) may improve diagnostic accuracy while providing prognostic value, especially in ASCA-seronegative patients

Read More about Unmasking Crohn’s Disease: Anti-glycan antibodies (ACCA, ALCA, AMCA) may improve diagnostic accuracy while providing prognostic value, especially in ASCA-seronegative patients
Posters  —  27 November Nov 2024

Biologic drug and anti-drug antibody monitoring: TNF inhibitors infliximab, adalimumab and certolizumab pegol in 128,537 patient samples

Read More about Biologic drug and anti-drug antibody monitoring: TNF inhibitors infliximab, adalimumab and certolizumab pegol in 128,537 patient samples
Posters  —  27 November Nov 2024

New blood-based test, 7 alpha-hydroxy-4-cholesten-3-one (7AlphaC4), for bile acid malabsorption/bile acid diarrhea in inflammatory bowel disease or unspecified diarrhea

Read More about New blood-based test, 7 alpha-hydroxy-4-cholesten-3-one (7AlphaC4), for bile acid malabsorption/bile acid diarrhea in inflammatory bowel disease or unspecified diarrhea
Posters  —  23 November Nov 2024

Comprehensive genomic and immune profiling for the detection of clinically significant tumor biomarkers

Read More about Comprehensive genomic and immune profiling for the detection of clinically significant tumor biomarkers
Posters  —  23 November Nov 2024

Validation of automated nucleic acid extraction using Covaris® Gen3 extraction methodology on the Assay-Ready Workstation

Read More about Validation of automated nucleic acid extraction using Covaris® Gen3 extraction methodology on the Assay-Ready Workstation
Posters  —  23 November Nov 2024

Analytical validation of OmniSeq® INSIGHT whole exome sequencing assay to facilitate precision oncology through tumor only testing in solid tumors

Read More about Analytical validation of OmniSeq® INSIGHT whole exome sequencing assay to facilitate precision oncology through tumor only testing in solid tumors
Posters  —  23 November Nov 2024

Analytical validation of OmniSeq® INSIGHT whole transcriptome sequencing assay to facilitate precision oncology through tumoronly testing in solid tumors

Read More about Analytical validation of OmniSeq® INSIGHT whole transcriptome sequencing assay to facilitate precision oncology through tumoronly testing in solid tumors
Posters  —  23 November Nov 2024

Enabling Access to Genomic Profiling through Decentralized Liquid Biopsy Solution PGDx elioTM plasma focus Dx

Read More about Enabling Access to Genomic Profiling through Decentralized Liquid Biopsy Solution PGDx elioTM plasma focus Dx
Posters  —  17 November Nov 2024

A 29-day two-dose and 3-day one-dose research and development study of intrathecal injection or epidural infusion in rats

Read More about A 29-day two-dose and 3-day one-dose research and development study of intrathecal injection or epidural infusion in rats
Posters  —  17 November Nov 2024

Assessment of leading regulatory T cell immunophenotyping methods using flow cytometry

Read More about Assessment of leading regulatory T cell immunophenotyping methods using flow cytometry